Quality of Life and Fixed-ratio Combination of Insulin Degludec and Liraglutide (iDegLira)

Summary

This work is aimed at improving the quality of life of older patients affected by type 2 diabetes. The investigators will try to amiliorate the complexity of hypogliceamic treatment in a little group of older patients with type 2 diabetes reducing the number of pills and/or insulin administration using a single daily dose of a fixed combination of insulin degludec and liraglutide. This therapeutic semplification will be done indipendently of pre-existent glicaemic control.

Timeline

Start

2018-11-19

Primary completion

2019-11-22

Completion

2021-03-25

Drugs

Indications